A look at the shareholders of BBI Life Sciences Corporation (HKG:1035) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that used to be publicly owned tend to have lower insider ownership.
With a market capitalization of HK$1.54b, BBI Life Sciences is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. We can zoom in on the different ownership groups, to learn more about 1035.
See our latest analysis for BBI Life Sciences
What Does The Institutional Ownership Tell Us About BBI Life Sciences?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
BBI Life Sciences already has institutions on the share registry. Indeed, they own 22.0% of the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It’s therefore worth looking at BBI Life Sciences’s earnings history, below. Of course, the future is what really matters.
We note that hedge funds don’t have a meaningful investment in BBI Life Sciences. There is some analyst coverage of the stock, but it could still become more well known, with time.
Insider Ownership Of BBI Life Sciences
The definition of company insiders can be subjective, and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Shareholders would probably be interested to learn that insiders own shares in BBI Life Sciences Corporation. In their own names, insiders own HK$24.4m worth of stock in the HK$1.54b company. Some would say this shows alignment of interests between shareholders and the board, though I generally prefer to see bigger insider holdings. But it might be worth checking if those insiders have been selling.